创伤后急性呼吸窘迫综合征、急性肾损伤和死亡与syndecan-1、可溶性血栓调节蛋白及晚期糖基化终产物受体循环增加相关
本文为PROPPR试验的二次分析,比较创伤后按1:1:1与1:1:2比例输注血小板、血浆和红细胞对血浆syndecan-1、可溶性血栓调节蛋白(sTM)和晚期糖基化终产物受体(RAGE)循环水平的影响。共分析1:1:1组308例和1:1:2组291例,各时间点两组间三种标志物均无统计学显著差异(p>0.05)。发生ARDS、AKI和死亡的患者在多数时间点生物标志物表达显著高于未发生者(p<0.05)。作者认为1:1:1比例血浆不持续影响创伤后内皮生物标志物循环,而ARDS、AKI和死亡与内皮生物标志物循环增加相关。
要点
- PROPPR二次分析中,1:1:1组308例与1:1:2组291例在入院及2、4、6、12、24、48、72小时各时间点syndecan-1、sTM、RAGE均无统计学显著差异(p>0.05)。
- 发生ARDS、AKI和死亡的患者在多数时间点三种内皮生物标志物表达显著高于未发生这些结局者(p<0.05)。
- 作者结论:1:1:1比例新鲜冰冻血浆与1:1:2相比不持续影响严重创伤后内皮生物标志物循环。
- 创伤后ARDS、AKI和死亡与内皮生物标志物循环增加相关,提示内皮损伤可能参与这些不良结局。
- 研究证据等级为治疗/管理Level III。
适用人群与场景
- PROPPR试验中接受创伤后复苏、输注血小板、血浆和红细胞的患者,纳入1:1:1组308例和1:1:2组291例进行分析。
- 排除生存时间不超过3小时或可用数据时间点少于两个的患者。
处置流程与药物剂量
- 比较两种复苏比例:血小板、血浆和红细胞按1:1:1比例输注 vs 按1:1:2比例输注。
- 于入院时及2小时、4小时、6小时、12小时、24小时、48小时、72小时定量检测syndecan-1、可溶性血栓调节蛋白(sTM)和晚期糖基化终产物受体(RAGE)。
研究设计与关键结果
- 研究类型:PROPPR试验的二次分析,比较1:1:1与1:1:2比例输注血小板、血浆和红细胞对创伤后内皮生物标志物循环的影响。
- 样本量:1:1:1组308例,1:1:2组291例。
- 主要终点结果:各时间点两组间syndecan-1、sTM、RAGE均无统计学显著差异(p>0.05)。
- 关键次要终点:发生ARDS、AKI和死亡的患者在多数时间点三种生物标志物表达显著高于未发生者(p<0.05)。
证据类型、等级与局限
- 证据类型:PROPPR试验的二次分析。
- 证据等级:治疗/管理Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:与1:1:2比例相比,1:1:1比例新鲜冰冻血浆不持续影响严重创伤后内皮生物标志物循环。
- 作者结论:创伤后ARDS、AKI和死亡的发生与内皮生物标志物循环增加相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Disruption of the vascular endothelium and endothelial glycocalyx (EG) has been described after severe trauma. Plasma has been suggested to restore microvascular integrity by preservation and repair of the EG. We sought to evaluate whether plasma administered in a 1:1:1 ratio was associated with less endothelial marker circulation than a 1:1:2 ratio.
METHODS: This is a secondary analysis of the PROPPR trial, which investigated post-traumatic resuscitation with platelets, plasma, and red blood cells in a 1:1:1 ratio compared with a 1:1:2 ratio. Syndecan-1, soluble thrombomodulin (sTM), and receptor for advanced glycation end products (RAGE) were quantified for each treatment group on admission and at 2 hours, 4 hours, 6 hours, 12 hours, 24 hours, 48 hours, and 72 hours. Patients were excluded if they did not survive longer than 3 hours or had data from fewer than two time points.
RESULTS: Three hundred eight patients in the 1:1:1 group and 291 in the 1:1:2 group were analyzed. There were no statistically significant differences in syndecan-1, sTM, or RAGE between treatment groups at any time point ( p > 0.05). Patients who developed acute respiratory distress syndrome, acute kidney injury, and death had significantly elevated biomarker expression at most time points when compared with patients who did not develop these sequelae ( p < 0.05).
CONCLUSION: Administration of FFP in a 1:1:1 ratio does not consistently affect circulation of endothelial biomarkers following significant trauma when compared with a 1:1:2 ratio. The development of post-traumatic ARDS, AKI, and death was associated with increased endothelial biomarker circulation.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Dixon A, Kenny JE, Buzzard L, et al. Acute respiratory distress syndrome, acute kidney injury, and mortality after trauma are associated with increased circulation of syndecan-1, soluble thrombomodulin, and receptor for advanced glycation end products. J Trauma Acute Care Surg. 2023. PMID: 37678154. doi:10.1097/TA.0000000000004096
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。